Researchers
Pešović, Jovan
Results 21-40 of 133
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Phosphorylated neurofilament heavy chain in cerebrospinal fluid and plasma as a Nusinersen treatment response marker in childhood-onset SMA individuals from Serbia![]() | Brkušanin, Miloš | Article | 21M21 |
| 2024 | Sleep problems in female carriers of premutation in the FMR1 gene![]() | Pešić, Milica | Conference Paper | Mp. category will be shown later |
| 2024 | Longitudinal analysis of CTG repeat somatic instability in myotonic dystrophy type 1 patients![]() | Radovanović, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Main features and disease outcome of congenital myotonic dystrophy- experience from a single tertiary center![]() | Ostojić, Slavica B.; Kovačević, Gordana S. | Article | 22M22 |
| 2023 | Dissemination of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa in Serbian Hospital Settings: Expansion of ST235 and ST654 Clones![]() | Kabic, Jovana | Article | 21M21 |
| 2023 | Sekvenciranje dugih fragmenata – sledeći nivo genomskih istraživanja![]() | Savić-Pavićević, Dušanka | Book parts | Mp. category will be shown later |
| 2023 | Mutation rates of 22 autosomal STR loci in a European population from Central Balkan, Republic of Serbia![]() | Nemanja Garai | Conference Paper | Mp. category will be shown later |
| 2023 | Dynamics of CTG repeat expansion in blood of Myotonic Dystrophy Type 1 patients over time | Radovanović, Nemanja | Conference Paper | Mp. category will be shown later |
| 2023 | Neurofilament as a biomarker of response to genetically designed therapies for spinal muscular atrophy | Brkušanin, Miloš | Conference Paper | Mp. category will be shown later |
| 2023 | Genetic risk factors in patients with Myasthenia gravis![]() | Garai Nemanja | Conference Paper | Mp. category will be shown later |
| 2022 | Cognitive assessment in patients with myotonic dystrophy type 2![]() | Perić, Stojan | Article | 21M21 |
| 2022 | Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2![]() | Perić, Stojan | Article | 21M21 |
| 2022 | Myotonic Dystrophy Type 2 and Autoimmune Diseases | Perić, S.; Zlatar J,; Pešović, Jovan | Conference Paper | Mp. category will be shown later |
| 2022 | LTBP4, SPP1, and CD40 Variants: Genetic Modifiers of Duchenne Muscular Dystrophy Analyzed in Serbian Patients![]() | Kosac, Ana | Article | 22M22 |
| 2022 | CpG места у околини DMPK експанзија са варијантним мотивима су хетерогено метилована код болесника са миотоничном дистрофијом тип 1 | Пешовић, Јован | Conference Paper | Mp. category will be shown later |
| 2022 | Analysis of circulating myomiRs as potential biomarkers of progression of muscular impairment in myotonic dystrophy type 1 patients | Radovanović, Nemanja | Conference Paper | Mp. category will be shown later |
| 2022 | EPR-083 Clinical score for early diagnosis of myotonic dystrophy type 2![]() | Ivanović, Vukan | Conference Paper | Mp. category will be shown later |
| 2022 | Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1![]() | Perić, Stojan | Article | 21M21 |
| 2022 | Кластер анализа фенотипских карактеристика пацијената који болују од миотоничне дистрофије типа 2 | Раденковић, Лана | Conference Paper | Mp. category will be shown later |
| 2022 | Analysis of Phenotypic Characteristics in patients with Myotonic dystrophy type 2 | Radenković, Lana | Conference Paper | Mp. category will be shown later |
